ライフサイエンスコーパス: thalamotomy

1 s treated with MRI-guided focused ultrasound thalamotomy.

2 ed before, 1 month after, and 6 months after thalamotomy.

3 before and after left ventralis intermedius thalamotomy.

4 atients with ET or TDPD who underwent MRgFUS thalamotomy.

5 t Parkinson's disease patients who underwent thalamotomy.

6 of 23 points (IQR, 15.5-34.0) following FUS thalamotomy and 1 point (IQR, -5.0 to 9.0) from a baseli

7 of 17 points (IQR, 10.5-27.5) following FUS thalamotomy and 22% (IQR, -11% to 29%) from a baseline o

8 uate white matter integrity before and after thalamotomy and its correlation with clinical outcome.

9 gical therapies include ablative techniques (thalamotomy and pallidotomy), augmentative techniques (n

10 ET (number 4) had a good response to a left thalamotomy and then suffered a right cerebellar hemisph

11 y patients were randomized to unilateral FUS thalamotomy, and 7 to sham procedure.

12 f 123 cases of MRI-guided focused ultrasound thalamotomy, and explore the relationships between treat

13 Ablative techniques include pallidotomy, thalamotomy, and, more recently, subthalamotomy.

14 Deep brain stimulation and ultrasound thalamotomy are surgical options in patients with medica

15 All patients undergoing focused ultrasound thalamotomy by a single surgeon were included.

16 Stereotaxic surgery, such as thalamotomy, can effectively reduce tremors.

17 g after MR imaging-guided focused ultrasound thalamotomy depicts changes in specific brain structures

18 Focused ultrasound thalamotomy for patients with TDPD demonstrated improvem

19 ting for placebo response, of unilateral FUS thalamotomy for patients with TDPD.

20 f transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor.

21 MR-guided focused ultrasound (MRgFUS) thalamotomy has been shown to be a safe and effective tr

22 MRI-guided focused ultrasound thalamotomy has been shown to be an effective treatment

23 med the efficacy of focused ultrasound (FUS) thalamotomy in essential tremor, but its effectiveness a

24 n normalized contrast (NC) of chronic MRgFUS thalamotomy-induced lesions compared with T2-weighted im

25 this pilot study suggest that radiosurgical thalamotomy is a promising treatment for medically refra

26 resonance-guided focused ultrasound (MRgFUS) thalamotomy is an effective treatment for medically refr

27 Stereotactic thalamotomy is an effective treatment for severe drug-re

28 izing MRI-guided focused ultrasound (MRgFUS) thalamotomy lesions in essential tremor (ET) and tremor-

29 otactic radiosurgical pallidotomy (n = 2) or thalamotomy (n = 15).

30 Background MRI-guided focused US thalamotomy of ventral intermediate nucleus of the thala

31 Two patients underwent thalamotomies, one of whom improved.

32 ligible, and 27 were randomized (2:1) to FUS thalamotomy or a sham procedure at 2 centers from Octobe

33 e safely and are an effective alternative to thalamotomy, pallidotomy and unilateral STN DBS for the

34 Thalamotomy relieved tremor but, as predicted, led to de

35 Conclusion MRI-guided focused US thalamotomy resulted in short- and long-term white-matte

36 single surgeon series of focused ultrasound thalamotomy to date, demonstrating tremor relief and adv

37 or (ET) or Parkinson disease (PD) undergoing thalamotomy were prospectively recruited between March 2

38 us, however, facilitates motor activity, and thalamotomy would be predicted to inhibit movement-assoc